Agilent Technologies (A) & LeMaitre Vascular (LMAT) Head-To-Head Comparison
Agilent Technologies (NYSE: A) and LeMaitre Vascular (NASDAQ:LMAT) are both computer and technology companies, but which is the better investment? We will contrast the two businesses based on the strength of their risk, analyst recommendations, valuation, institutional ownership, profitability, earnings and dividends.
This is a breakdown of current ratings and recommmendations for Agilent Technologies and LeMaitre Vascular, as provided by MarketBeat.com.
|Sell Ratings||Hold Ratings||Buy Ratings||Strong Buy Ratings||Rating Score|
Agilent Technologies currently has a consensus target price of $65.14, indicating a potential downside of 1.42%. LeMaitre Vascular has a consensus target price of $28.60, indicating a potential downside of 26.91%. Given Agilent Technologies’ stronger consensus rating and higher probable upside, equities research analysts plainly believe Agilent Technologies is more favorable than LeMaitre Vascular.
Risk & Volatility
Agilent Technologies has a beta of 1.3, indicating that its stock price is 30% more volatile than the S&P 500. Comparatively, LeMaitre Vascular has a beta of 0.67, indicating that its stock price is 33% less volatile than the S&P 500.
Earnings & Valuation
This table compares Agilent Technologies and LeMaitre Vascular’s top-line revenue, earnings per share and valuation.
|Gross Revenue||Price/Sales Ratio||EBITDA||Earnings Per Share||Price/Earnings Ratio|
|Agilent Technologies||$4.39 billion||4.84||$1.02 billion||$1.94||34.06|
|LeMaitre Vascular||$96.40 million||7.72||$23.12 million||$0.69||56.71|
Agilent Technologies has higher revenue and earnings than LeMaitre Vascular. Agilent Technologies is trading at a lower price-to-earnings ratio than LeMaitre Vascular, indicating that it is currently the more affordable of the two stocks.
Institutional & Insider Ownership
66.3% of LeMaitre Vascular shares are held by institutional investors. 23.7% of LeMaitre Vascular shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term.
This table compares Agilent Technologies and LeMaitre Vascular’s net margins, return on equity and return on assets.
|Net Margins||Return on Equity||Return on Assets|
Agilent Technologies pays an annual dividend of $0.53 per share and has a dividend yield of 0.8%. LeMaitre Vascular pays an annual dividend of $0.22 per share and has a dividend yield of 0.6%. Agilent Technologies pays out 27.3% of its earnings in the form of a dividend. LeMaitre Vascular pays out 31.9% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years. Agilent Technologies is clearly the better dividend stock, given its higher yield and lower payout ratio.
Agilent Technologies beats LeMaitre Vascular on 11 of the 16 factors compared between the two stocks.
About Agilent Technologies
Agilent Technologies, Inc. provides application focused solutions that include instruments, software, services and consumables for the entire laboratory workflow. The Company serves the life sciences, diagnostics and applied chemical markets. It has three business segments: life sciences and applied markets business, diagnostics and genomics business, and Agilent CrossLab business. Its life sciences and applied markets business segment offers instruments and software that enable customers to identify, quantify and analyze the physical and biological properties of substances and products, as well as enable customers in the clinical and life sciences research areas to interrogate samples at the molecular level. Its diagnostics and genomics business segment includes the reagent partnership, pathology, companion diagnostics, genomics and the nucleic acid solutions businesses. Its Agilent CrossLab business segment spans the entire lab with its consumables and services portfolio.
About LeMaitre Vascular
LeMaitre Vascular, Inc. is a provider of medical devices for the treatment of peripheral vascular disease. The Company develops, manufactures and markets medical devices and implants used primarily in the field of vascular surgery. It is engaged in the design, marketing, sales and technical support of medical devices and implants for the treatment of peripheral vascular disease industry segment. The Company’s product lines include valvulotomes, balloon catheters, carotid shunts, biologic vascular patches, radiopaque marking tape, anastomotic clips, remote endarterectomy devices, laparoscopic cholecystectomy devices, prosthetic vascular grafts, biologic vascular grafts and powered phlebectomy devices. Its portfolio of peripheral vascular devices consists of brand name products that are used in arteries and veins outside of the heart, including the Expandable LeMaitre Valvulotome, the Pruitt F3 Carotid Shunt, VascuTape Radiopaque Tape and the XenoSure biologic patch.
Receive News & Ratings for Agilent Technologies Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Agilent Technologies Inc. and related companies with MarketBeat.com's FREE daily email newsletter.